The United States Food and Drug Administration (USFDA) has classified the inspection conducted at its Goa manufacturing facility from 16-27 September 2019 as Official Action Indicated (OAI).
The Company does not believe that this will have any material impact on the US business at this stage. The Company has a strong track record of maintaining the highest standard of compliance and will work closely with the agency to comprehensively address the observations received.
Shares of CIPLA LTD. was last trading in BSE at Rs.470.3 as compared to the previous close of Rs. 473.25. The total number of shares traded during the day was 27256 in over 1506 trades.
The stock hit an intraday high of Rs. 480 and intraday low of 470.3. The net turnover during the day was Rs. 12973446.